Provided by Tiger Trade Technology Pte. Ltd.

WUXI BIO

45.860
+4.48010.83%
Volume:76.32M
Turnover:3.39B
Market Cap:190.09B
PE:33.96
High:45.980
Open:41.360
Low:41.020
Close:41.380
52wk High:45.980
52wk Low:28.480
Shares:4.15B
HK Float Shares:4.15B
Volume Ratio:2.29
T/O Rate:1.84%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.350
ROE:11.64%
ROA:6.88%
PB:3.46
PE(LYR):33.96
PS:7.50

Loading ...

Biotech ETF Gains Over 5% as Leading Innovators Report Strong Earnings and Global Supply Chain Remains Robust

Stock News
·
Aug 07

Hong Kong Market Movers: Innovative Drug Stocks Rally as Earnings Season Approaches, Medical Conferences Expected to Provide Catalysts

Stock News
·
Aug 07

WuXi Bio Co., Ltd. gains nearly 6% in early trading, plans to acquire ChuangSheng Pharma's process development and manufacturing base in Hangzhou

Deep News
·
Aug 07

Movement Alert|WUXI BIO Rises 3.19% in Regular Trading, CXO Sector Rallies on Strong Peer Earnings and Upcoming Interim Results

Market Focus
·
Aug 07

Transcenta Agrees to Sell CDMO Assets to WuXi Biologics Unit for RMB 190 Million

Reuters
·
Aug 07

Whitehawk Q2 FY26 Net Loss Narrows to $16.64 Million

Reuters
·
Aug 06

Wuxi Biologics (Cayman) Stock Advances 1.9% in Hong Kong

Dow Jones
·
Aug 06

Movement Alert|WUXI BIO Rises 3.1% in Regular Trading, CXO Sector Strength and Interim Earnings Expectations Serve as Catalysts

Market Focus
·
Aug 06

Wuxi Biologics (Cayman) Stock Climbs 4.3% in Hong Kong

Dow Jones
·
Aug 04

CRO Stocks Surge: Multiple Overseas MNCs and CXO Firms Report Strong Interim Results, Raise Full-Year Guidance

Stock News
·
Aug 04

Hong Kong Market Opens Higher as Pharma and Tech Stocks Lead Gains

Stock News
·
Aug 04

Movement Alert|WUXI BIO Rises 4.85% in Regular Trading, CXO Sector Broad Rally Lifts Life Sciences Stocks

Market Focus
·
Aug 04

Wuxi Biologics (Cayman) Stock Rallies 2.5% in Hong Kong

Dow Jones
·
Jul 31

Hong Kong Stock Movers: Several Innovative Drug Stocks Rally in Afternoon Trading, GENSCRIPT BIO Surges Nearly 8%, REMEGEN Gains Over 4%

Stock News
·
Jul 31

Movement Alert|WUXI BIO Rises 3.07% in Regular Trading, CXO Sector Rallies on Accelerating Industry Recovery

Market Focus
·
Jul 31

Wuxi Biologics (Cayman) Stock Slips 4.0% in Hong Kong

Dow Jones
·
Jul 30

Movement Alert|WUXI BIO Falls 3.15% in Regular Trading, Life Sciences Sector Broadly Weakens as Subsidiary Faces Target Price Cut

Market Focus
·
Jul 30

WuXi Biologics Added to FTSE4Good Index Series for Sixth Straight Year

Reuters
·
Jul 29

Nomura Adjusts WuXi Biologics (Cayman)'s Price Target to HK$51.38 From HK$50.54, Keeps at Buy

MT Newswires Live
·
Jul 27

WuXi Biologics Schedules 25 August Board Meeting to Approve H1 2026 Results

Bulletin Express
·
Jul 24